Mom's Garden Launches Innovative Collagen Product at CICPE in Hainan
The 6th China International Consumer Products Expo (CICPE) was held in Hainan on April 13, 2026, marking a significant event in the realm of consumer goods. Among the notable participants was Mom's Garden, a prominent German brand specializing in bone health. They formally introduced their latest product, 'iFlex,' designed specifically to cater to the evolving health needs of Chinese consumers.
For years, conventional joint care approached issues by only alleviating surface-level symptoms. However, the research and development (R&D) team at Mom's Garden has recognized that genuine joint discomfort stems from structural deterioration of cartilage. Their newly released 'iFlex' product is crafted using a patented formula that actively targets inflammatory responses and significantly repairs the underlying collagen fiber network in cartilage, likened to a robust 'steel framework.' This dual-action method not only addresses immediate pain but aims to restore the integrity of joint structures themselves.
During the expo, Ms. Olga Stepanko, the Global Brand Manager of Mom's Garden, emphasized the profound impact of joint pain on individuals lives, asserting that true scientific advancements should promote freedom of movement. In her words, "Joint pain limits people's pursuit of a better quality of life. The ultimate goal of scientific innovation should not be data alone, but to empower individuals with genuine freedom of movement."
Mom's Garden has previously engaged in initiatives like the Expert Recommendations on Bone and Joint Health for Middle-aged and Older Adults, and their participation in the CICPE further affirms their dedication to science-backed, localized health solutions for consumers in China. Collaborative forums and discussions at the expo showcased the brand's ongoing commitment to integrate local insights with their international expertise.
Looking ahead, Mom's Garden aims to enhance its collaborative efforts between Germany and China focused on R&D, enrich its portfolio with evidence-based products, and fast-track its localized development plans. The introduction of 'iFlex' marks not just a product launch, but a significant step towards addressing consumer health needs with serious commitment to innovation and quality.
This collaboration reflects a blend of global knowledge and localized needs, as Mom's Garden continues to adapt its strategies to fit the unique demands of the Chinese market, promising to lead the way in the bone health sector. The launch of iFlex is just the beginning of many initiatives aimed at transforming joint health for consumers around the world.
For years, conventional joint care approached issues by only alleviating surface-level symptoms. However, the research and development (R&D) team at Mom's Garden has recognized that genuine joint discomfort stems from structural deterioration of cartilage. Their newly released 'iFlex' product is crafted using a patented formula that actively targets inflammatory responses and significantly repairs the underlying collagen fiber network in cartilage, likened to a robust 'steel framework.' This dual-action method not only addresses immediate pain but aims to restore the integrity of joint structures themselves.
During the expo, Ms. Olga Stepanko, the Global Brand Manager of Mom's Garden, emphasized the profound impact of joint pain on individuals lives, asserting that true scientific advancements should promote freedom of movement. In her words, "Joint pain limits people's pursuit of a better quality of life. The ultimate goal of scientific innovation should not be data alone, but to empower individuals with genuine freedom of movement."
Mom's Garden has previously engaged in initiatives like the Expert Recommendations on Bone and Joint Health for Middle-aged and Older Adults, and their participation in the CICPE further affirms their dedication to science-backed, localized health solutions for consumers in China. Collaborative forums and discussions at the expo showcased the brand's ongoing commitment to integrate local insights with their international expertise.
Looking ahead, Mom's Garden aims to enhance its collaborative efforts between Germany and China focused on R&D, enrich its portfolio with evidence-based products, and fast-track its localized development plans. The introduction of 'iFlex' marks not just a product launch, but a significant step towards addressing consumer health needs with serious commitment to innovation and quality.
This collaboration reflects a blend of global knowledge and localized needs, as Mom's Garden continues to adapt its strategies to fit the unique demands of the Chinese market, promising to lead the way in the bone health sector. The launch of iFlex is just the beginning of many initiatives aimed at transforming joint health for consumers around the world.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.